Precision Medicine Global Congress 2026 Europe
London, United Kingdom | Thursday 14th - Friday 15th May 2026
Translating scientific breakthroughs into scalable clinical systems
09:00 - OPENING KEYNOTE PANEL: Scaling Personalised Medicine: From Innovation to System-Level Impact
- Moving beyond pilot programs to national-scale implementation
- Aligning regulatory pathways with innovation speed
- Evidence generation: what payers and governments require
- Co-development models (drug + diagnostic + digital companion)
- Embedding patient voice early in therapeutic design
- Analyzing current adoption rates and regional developments across international markets.
- Examining the evolving frameworks designed to bring personalized therapies to market more efficiently.
- Identifying the systemic and technological hurdles that currently limit widespread scalability.
- Developing actionable strategies to integrate these advancements into standard healthcare delivery.
- Explore the integration of genomics, transcriptomics, proteomics, and metabolomics
- Focus on the role of systems biology in disease stratification
- Address the clinical validation of multi-omic signatures
- The ongoing challenges regarding data interoperability
- Strategies for translating these complex datasets into physician-ready insights that can be applied in a
clinical setting.
- Transitioning from research sequencing to clinical-grade pipelines
- Harmonizing variant interpretation across institutions
- Integrating genomic data into hospital EHR systems
- Accreditation, quality assurance, and compliance frameworks
- Workforce and bioinformatics capacity building
- Embedding PGx into electronic health record-based prescribing systems to provide real-time decision support.
- Utilizing genotype-guided therapy to significantly reduce adverse drug reactions.
- Establishing robust cost-effectiveness evidence to secure support from payers.
- Developing national implementation frameworks to standardize practices.
- Identifying and overcoming barriers to clinician adoption through education and streamlined workflows.
- Strategies for aligning drug and diagnostic timelines.
- Navigating cross-agency requirements and ensuring compliance.
- Standards for establishing clinical validity and utility.
- Synchronizing strategies between pharmaceutical and diagnostic partners to ensure market access and sustainable reimbursement.
The Data-Driven Infrastructure of Precision Medicine
- Examining computational models for treatment optimization
- Use of predictive modeling for disease progression.
- The integration of wearable and remote monitoring data to enhance model accuracy.
- Ethical implications of predictive health forecasting
- Practical challenges of clinical adoption and reimbursement.
- Multi-modal AI models integrating imaging, omics, and EHR data
- Validation frameworks for AI-derived biomarkers
- Bias detection and mitigation in training datasets
- Regulatory approval pathways for AI-driven diagnostics
- Real-world performance monitoring
- Leveraging longitudinal EHR and claims data
- Synthetic control arms in rare disease trials
- Data standardization and quality frameworks
- Global regulatory acceptance trends
- RWE in post-market surveillance
- Focus on establishing cross-border genomic data sharing frameworks
- Implementation of federated AI models that function without the need for centralizing sensitive data.
- Addressing critical cyber security threats facing genomic infrastructure and the modernization of patient consent processes.
- Effective strategies that balances technological innovation with the maintenance of public trust.
- Implementation of basket, umbrella, and platform trial designs
- Biomarker-driven patient stratification to ensure more targeted treatment.
- Transition toward decentralized and hybrid trial models to increase patient accessibility
- AI-assisted patient recruitment and advocating for the global harmonization of trial regulations.
- Who owns genomic and real-world data?
- Public-private data partnerships: risks and opportunities
- Balancing innovation with privacy protection
- Data standardization and interoperability challenges
- Building patient trust in AI-driven healthcare